Bio-Sourcing

Belgium
Ligny, Wallonia, Belgium, 4000

Company profile

Bio-Sourcing company profile

BioSourcing is developing a New Generation of Biotherapeutics, in particular Monoclonal Antibodies for Global Unmet Medical Needs : Available, Affordable, Sustainable. BioSourcing changes the design paradigm of these new biotherapeutics thanks to the mastery of several breakthrough technologies including genome editing (CRISPR). The BioSourcing disruptive approach leads to a drastic reduction in capital requirements and production costs, especially for large volumes, as well as an improvement in the quality/efficiency of biopharmaceuticals through better glycosylation. BioSourcing strongly contributes to sustainable development, in particular in drasticly reducing the carbon footprint. BioSourcing is a fully operational biotechnology company, based in Liège, Belgium. Its team is made up of the best scientists, international experts in their field and has developed strategic partnerships with leaders in the pharmaceutical and biotechnology industry.

Business identity

Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2014-01-01, Year

Headquarters

Postal code
4000
Country code
BE
Continent
Europe

Capital profile

Funding and company signals

Funding rounds
3
Total equity funding
$11.2M
Last funding
Grant / 2026-01-12
Last equity funding
Series Unknown / $11.2M
Investors
2
Lead investors
2
Articles
9

Founders and investors

Lead investors

EIC AcceleratorEurostars

Investors

EIC AcceleratorEurostars